Cargando…

Proteomic Profiling Identifies Kaposi’s Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANA(SIM)-Associated Proteins in Hypoxia

Hypoxia signaling is a key regulator in the development and progression of many types of human malignancies, including viral cancers. The latency-associated nuclear antigen (LANA), encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV) during latency, is a multifunctional protein that plays an es...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaoqing, Gan, Jin, Du, Shujuan, Zhu, Caixia, Wang, Yuyan, Jia, Yuping, Zhang, Daizhou, Qu, Di, Wei, Fang, Robertson, Erle S., Cai, Qiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562486/ https://www.ncbi.nlm.nih.gov/pubmed/34726485 http://dx.doi.org/10.1128/mSystems.01109-21

Ejemplares similares

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy
por: Lang, Fengchao, et al.
Publicado: (2018)

A Unique SUMO-2-Interacting Motif within LANA Is Essential for KSHV Latency
por: Cai, Qiliang, et al.
Publicado: (2013)

IRF-4-Mediated CIITA Transcription Is Blocked by KSHV Encoded LANA to Inhibit MHC II Presentation
por: Cai, Qiliang, et al.
Publicado: (2013)

Correction: Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy
por: Lang, Fengchao, et al.
Publicado: (2019)

Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA
por: Wei, Fang, et al.
Publicado: (2016)

Upregulation of Cell Surface Glycoproteins in Correlation with KSHV LANA in the Kaposi Sarcoma Tumor Microenvironment
por: Privatt, Sara R., et al.
Publicado: (2023)

Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
por: Dedicoat, M, et al.
Publicado: (2003)

KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation
por: Singh, Rajnish Kumar, et al.
Publicado: (2019)

Efficient lytic induction of kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines
por: Kang, Hyunju, et al.
Publicado: (2014)

Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
por: Wakeham, Katie, et al.
Publicado: (2011)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Next-Generation Sequencing in the Understanding of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Biology
por: Strahan, Roxanne, et al.
Publicado: (2016)

Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi’s Sarcoma-Associated Herpesvirus for Viral Latency
por: Wang, Chong, et al.
Publicado: (2017)

Epigenetic Reprogramming of Kaposi’s Sarcoma-Associated Herpesvirus during Hypoxic Reactivation
por: Singh, Rajnish Kumar, et al.
Publicado: (2022)

In Vivo Persistence of Chimeric Virus after Substitution of the Kaposi's Sarcoma-Associated Herpesvirus LANA DNA Binding Domain with That of Murid Herpesvirus 4
por: Pires de Miranda, Marta, et al.
Publicado: (2018)

Post-Translational Modifications of Kaposi’s Sarcoma-Associated Herpesvirus Regulatory Proteins – SUMO and KSHV
por: Campbell, Mel, et al.
Publicado: (2012)

Lytic Reactivation of the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
por: Atari, Nofar, et al.
Publicado: (2022)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

Targeting Kaposi’s sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases
por: Rafeeq, Misbahuddin M, et al.
Publicado: (2023)

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
por: Newton, R, et al.
Publicado: (2003)

Disrupting Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor
por: Berwanger, Aylin, et al.
Publicado: (2023)

Cross-species conservation of episome maintenance provides a basis for in vivo investigation of Kaposi's sarcoma herpesvirus LANA
por: Habison, Aline C., et al.
Publicado: (2017)

The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
por: Mortazavi, Yasaman, et al.
Publicado: (2020)

NDRG1 facilitates lytic replication of Kaposi’s sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase
por: Dong, Lianghui, et al.
Publicado: (2021)

Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Down-Regulates IL-22R1 Expression through a Cis-Acting Element within the Promoter Region
por: Su, Ling, et al.
Publicado: (2011)

Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
por: Beachler, Dan, et al.
Publicado: (2010)

Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4(+) T Cells
por: Nicol, Samantha M., et al.
Publicado: (2016)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

Phosphorylation of the Chromatin Binding Domain of KSHV LANA
por: Woodard, Crystal, et al.
Publicado: (2012)

Kaposi's Sarcoma Herpesvirus Upregulates Aurora A Expression to Promote p53 Phosphorylation and Ubiquitylation
por: Cai, Qiliang, et al.
Publicado: (2012)

Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency
por: Mariggiò, Giuseppe, et al.
Publicado: (2017)

Experimental Transmission of Kaposi's Sarcoma–Associated Herpesvirus (Kshv/Hhv-8) to Scid-Hu Thy/Liv Mice
por: Dittmer, D., et al.
Publicado: (1999)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

EC(5)S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor Suppressors
por: Cai, Qi-Liang, et al.
Publicado: (2006)

Kaposi's sarcoma-associated herpesvirus at 27
por: Gaglia, Marta Maria
Publicado: (2021)

KSHV Reprogramming of Host Energy Metabolism for Pathogenesis
por: Liu, Xiaoqing, et al.
Publicado: (2021)

Upregulation of Cellular Bcl-2 by the KSHV Encoded RTA Promotes Virion Production
por: Gao, Jianming, et al.
Publicado: (2011)

NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
por: Hughes, David J., et al.
Publicado: (2015)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t0l2ocbdm6sca2ocfch7bv3neu